Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
    • COVID-19 submission information
  • Alerts
  • Subscriptions

Pirfenidone: an update on clinical trial data and insights from everyday practice

Michael Kreuter
European Respiratory Review 2014 23: 111-117; DOI: 10.1183/09059180.00008513
Michael Kreuter
1Dept of Pneumology and Respiratory Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, Heidelberg, Germany. 2Translational Lung Research Heidelberg (TLRC), Heidelberg, Germany, Member of the German Center for Lung Research.
1Dept of Pneumology and Respiratory Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, Heidelberg, Germany. 2Translational Lung Research Heidelberg (TLRC), Heidelberg, Germany, Member of the German Center for Lung Research.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kreuter@uni-heidelberg.de
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 23 no. 131 111-117
DOI 
https://doi.org/10.1183/09059180.00008513
PubMed 
24591668

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received December 6, 2013
  • Accepted January 8, 2014
  • Published online February 28, 2014.

Copyright & Usage 
©ERS 2014 ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 3.0.

Author Information

  1. Michael Kreuter1,2⇑
  1. 1Dept of Pneumology and Respiratory Critical Care Medicine, Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, Heidelberg, Germany. 2Translational Lung Research Heidelberg (TLRC), Heidelberg, Germany, Member of the German Center for Lung Research.
  1. M. Kreuter, Dept of Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg, Amalienstrasse 5, D-69126 Heidelberg, Germany. E-mail: kreuter{at}uni-heidelberg.de
View Full Text

Article usage

Article usage: February 2014 to February 2021

AbstractFullPdf
Feb 2014923
Mar 20141192400518
Apr 2014570207222
May 2014373147166
Jun 2014168138102
Jul 201413714596
Aug 201411010472
Sep 201416015189
Oct 201411117290
Nov 2014111184106
Dec 20149512679
Jan 20158415690
Feb 20157914289
Mar 20158814981
Apr 20157118797
May 20155317963
Jun 20156315980
Jul 20155613051
Aug 20155312245
Sep 20154212975
Oct 201523914453
Nov 201521112669
Dec 201512212840
Jan 201614011961
Feb 20161569240
Mar 20169516550
Apr 20167712960
May 201649329
Jun 201656923
Jul 201637528
Aug 201664618
Sep 2016177426
Oct 2016108927
Nov 20161211928
Dec 2016119341
Jan 201726117
Feb 201776222
Mar 201788420
Apr 201786323
May 201786113
Jun 201797120
Jul 201786426
Aug 201757414
Sep 201737016
Oct 2017104812
Nov 201797219
Dec 20172479
Jan 201844513
Feb 201815810
Mar 201884710
Apr 201855716
May 201868215
Jun 2018413216
Jul 2018213320
Aug 201829616
Sep 2018110112
Oct 2018113119
Nov 2018014626
Dec 2018411121
Jan 2019216821
Feb 2019217219
Mar 2019518531
Apr 2019015932
May 2019319114
Jun 2019412720
Jul 2019112421
Aug 20192934
Sep 2019470128
Oct 2019211818
Nov 201936715
Dec 201927922
Jan 202005212
Feb 202007013
Mar 202017419
Apr 202029816
May 202029125
Jun 202029727
Jul 202018824
Aug 202017819
Sep 2020511028
Oct 202029422
Nov 202037718
Dec 202039123
Jan 202109429
Feb 202116427

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 23 Issue 131 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pirfenidone: an update on clinical trial data and insights from everyday practice
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Pirfenidone: an update on clinical trial data and insights from everyday practice
Michael Kreuter
European Respiratory Review Mar 2014, 23 (131) 111-117; DOI: 10.1183/09059180.00008513

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Pirfenidone: an update on clinical trial data and insights from everyday practice
Michael Kreuter
European Respiratory Review Mar 2014, 23 (131) 111-117; DOI: 10.1183/09059180.00008513
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Introduction
    • Efficacy of pirfenidone: CAPACITY per-protocol analysis
    • Efficacy of pirfenidone in CAPACITY patients with FVC decline at 6 months
    • Pirfenidone longer term experience
    • Pirfenidone single-centre experience
    • Conclusion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Interstitial and orphan lung disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Asthma-COPD overlap: current understanding and experimental models
  • CF-related diabetes and lung disease
  • Corticosteroids for CAP, influenza and COVID-19
Show more Reviews

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2021 by the European Respiratory Society